Business · 08/08/2003Updated: 10/17/2026 · 1 min read
FDA Announces Approval of New Drug Patent Information Collection
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information related to patent submissions and 30-month stays on FDA approval of new drugs, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →